PR

SmartCella initiates Phase I/IIa clinical study with Extroducer® for targeted delivery of chemotherapy in pancreatic cancer

SmartCella inleder klinisk fas I/IIa studie med Extroducer® för riktad leverans av cytostatika vid bukspottkörtelcancer

SmartCella represents business sector in Swedish Government delegation to Boston